Gender Male
LinkedIn View on LinkedIn
Dennis Slamon is the Board Member and Director and Co-founder of TORL BioTherapeutics. Dennis Joseph Slamon (born August 6, 1948), is an American oncologist and chief of the division of Hematology-Oncology at UCLA. He is best known for his work identifying the HER2/neu oncogene that is amplified in 25-33% of breast cancer patients and the
resulting treatment trastuzumab.
